• If you are wondering whether Becton Dickinson stock is offering good value right now, a good starting point is to line up its recent share performance against what investors are paying for the business.
• The stock last closed at US$153.26, with returns of 2.8% over the past week, a 1.1% decline over 30 days, a 21.4% decline year to date, and an 18.8% gain over the past year, which gives a mixed picture of sentiment and risk.
• Recent news coverage around Becton Dickinson has focused on its role within the healthcare equipment space and how investors are weighing that against broader sector trends. This context helps explain why the share price has not moved in a straight line, even as the company remains a key player in its industry.
• Right now, Becton Dickinson has a valuation score of 5 out of 6, which suggests the stock screens as undervalued on most of the checks used. It therefore makes sense to look at how different valuation methods line up and then consider an even richer way to think about value later in the article.

Approach 1: Becton Dickinson Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects the cash a company is expected to generate in the future and then discounts those cash flows back to today to estimate what the business could be worth now.

For Becton Dickinson, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month free cash flow is about $3.0b. Analyst estimates cover the next few years. From there Simply Wall St extrapolates further, with projected free cash flow of $3.7b in 2030. The ten year path includes specific yearly projections from 2026 to 2035, each discounted back to today using this model.

Putting those discounted cash flows together, the DCF model arrives at an estimated intrinsic value of $236.80 per share, compared with the recent share price of $153.26. This implies the stock screens as about 35.3% undervalued on this method.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Becton Dickinson is undervalued by 35.3%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Becton Dickinson Price vs Earnings

For profitable companies, the P/E ratio is a straightforward way to see what you are paying for each dollar of earnings. It links the share price directly to profit, which tends to matter most over the long run for shareholders.

What counts as a “normal” P/E depends on what the market expects from a company and how risky those earnings appear. Higher expected growth and lower perceived risk usually support a higher P/E, while slower expected growth or higher risk tend to justify a lower one.

Becton Dickinson currently trades on a P/E of 26.50x. That sits above the Medical Equipment industry average of 24.14x, but below the peer group average of 29.98x. To refine this comparison, Simply Wall St uses a proprietary “Fair Ratio” of 28.07x for Becton Dickinson. This figure is designed to reflect the company’s specific profile, including earnings growth, profit margins, size, industry and identified risks, so it can be more tailored than a simple peer or industry check.

Comparing the current P/E of 26.50x with the Fair Ratio of 28.07x suggests the stock is trading below where this model would place it.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Becton Dickinson Narrative

Earlier it was mentioned that there is an even better way to understand valuation, and this is where Narratives come in, letting you attach a clear story about Becton Dickinson to specific assumptions on future revenue, earnings, margins and a Fair Value that you can compare to the current share price.

A Narrative on Simply Wall St is a short, structured story that you choose, which connects what you believe about the company, such as pressure from global research funding cuts or confidence in new products and margin programs, to a financial forecast and then to an estimated Fair Value.

These Narratives sit in the Community section of Simply Wall St, are designed to be easy to use, and are updated automatically when new information arrives, such as earnings, price target resets or fresh product news, so your chosen story and Fair Value keep reflecting the latest data without extra work from you.

For Becton Dickinson, one investor might align with a cautious Narrative that assumes revenue declines of around 3.1% a year, earnings of about US$2.3b by 2029 and a Fair Value of roughly US$157. Another investor might prefer a more optimistic Narrative that uses higher revenue growth, earnings of about US$3.3b by 2028 and a Fair Value closer to US$253. Comparing each Fair Value with the current price can then help you decide whether the stock appears expensive or cheap under the story you find most reasonable.

Do you think there's more to the story for Becton Dickinson? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.